David A Bailey

Title: David A. Bailey: Innovator in Yeast Gene Expression

Introduction

David A. Bailey is a notable inventor based in Brighton, MA (US). He has made significant contributions to the field of biotechnology, particularly in the area of gene expression in yeast. His innovative work has implications for both research and practical applications in antifungal compound development.

Latest Patents

David A. Bailey holds a patent for "Regulated gene expression in yeast and method of use." This invention provides novel yeast cells that comprise genes whose expression can be modulated by growth in the presence or absence of metal ions. The patent outlines methods for creating such yeast cells and describes their use in determining the requirement for the expression of specific genes for the growth or viability of the yeast cells. Additionally, the invention includes methods for using these yeast cells in the isolation, screening, and analysis of candidate antifungal compounds. He has 1 patent to his name.

Career Highlights

David A. Bailey is currently associated with Anadys Pharmaceuticals, Inc., where he continues to advance his research in biotechnology. His work at the company has positioned him as a key player in the development of innovative solutions in the pharmaceutical industry.

Collaborations

Throughout his career, David has collaborated with notable colleagues, including John D. Bradley and Craig M. Thompson. These collaborations have further enriched his research and contributed to the success of his projects.

Conclusion

David A. Bailey's contributions to the field of gene expression in yeast highlight his innovative spirit and dedication to advancing biotechnology. His work not only enhances our understanding of gene regulation but also paves the way for new antifungal treatments.